Reason for request
Re-assessment of the Actual Benefit and Renewal of inclusion
Clinical Benefit
| Low |
The actual benefit of the proprietary medicinal product NUCTALON is low in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia. " |
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
9XEpgweK9GE5dNMj
